| Product NDC: | 18860-121 | 
| Proprietary Name: | VERSACLOZ | 
| Non Proprietary Name: | Clozapine | 
| Active Ingredient(s): | 50 mg/mL & nbsp; Clozapine | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | SUSPENSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 18860-121 | 
| Labeler Name: | Jazz Pharmaceuticals, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA203479 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20130215 | 
| Package NDC: | 18860-121-01 | 
| Package Description: | 1 BOTTLE in 1 BOX (18860-121-01) > 100 mL in 1 BOTTLE | 
| NDC Code | 18860-121-01 | 
| Proprietary Name | VERSACLOZ | 
| Package Description | 1 BOTTLE in 1 BOX (18860-121-01) > 100 mL in 1 BOTTLE | 
| Product NDC | 18860-121 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Clozapine | 
| Dosage Form Name | SUSPENSION | 
| Route Name | ORAL | 
| Start Marketing Date | 20130215 | 
| Marketing Category Name | NDA | 
| Labeler Name | Jazz Pharmaceuticals, Inc. | 
| Substance Name | CLOZAPINE | 
| Strength Number | 50 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Atypical Antipsychotic [EPC] |